Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01165710 · ClinicalTrials.gov registry record
Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)
A clinical trial, sponsored by Janssen Scientific Affairs.
- Completed
- Registry status
- 10,179
- Enrollment target
NCT01165710: Completed study, sponsored by Janssen Scientific Affairs.
NCT01165710 is a clinical trial that has completed, run by Janssen Scientific Affairs. The registered enrollment target is 10,179 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01165710 has completed, sponsored by Janssen Scientific Affairs.
- COMPLETED
- Registry status
- 10,179 participants
- Enrollment target
Study Summary
The ORBIT-AF registry will be a multicenter, prospective outpatient disease registry to identify "real world" treatment patterns of atrial fibrillation. The registry will describe this patient population with regards to demographics, clinical factors, risk stratification, and geographic regions. In particular, attention will be focused on the utilization, effectiveness, and safety of antithrombotic therapies in the prevention of stroke. The registry is designed to identify reasons and risk factors for non-receipt of anticoagulation (AC) therapy, as well as reasons why AF patients who are prescribed AC therapy do not take them.
Interventions
- OTHER Patients with Atrial Fibrillation (AF)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,179 participants |
| Start Date | 2010-06 |
| Est. Completion | 2014-12 |
What the finished NCT01165710 record still lists
NCT01165710 is an observational study that tracks outcomes without assigning an intervention. Its 10,179 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Patients with Atrial Fibrillation (AF) is the first listed.
NCT01165710 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01165710 about?
NCT01165710 is a clinical study titled "Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)". The ORBIT-AF registry will be a multicenter, prospective outpatient disease registry to identify "real world" treatment patterns of atrial fibrillation. The registry will describe this patient population with regards to demographics, clinical factors, risk stratification, and geographic regions. In ...
What is the current status of trial NCT01165710?
This trial is currently completed. The enrollment target is 10,179 participants. The study started on 2010-06. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01165710?
The interventions under investigation include: Patients with Atrial Fibrillation (AF) (OTHER).
Who is sponsoring clinical trial NCT01165710?
This trial is sponsored by Janssen Scientific Affairs, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04332783 · 10,120 participants · NA
Isolating and Mitigating Sequentially Dependent Perceptual Errors in Clinical Visual Search
- NCT00160771 · 10,000 participants
Biomechanics/Motion Analysis Laboratory Data Bank
- NCT00896935 · 10,000 participants
Arizona Cancer Center Biospecimen Repository
- NCT00898235 · 10,000 participants
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia